Tag: antidepressant drug

Drug or Exercise for Geriatric Depression? It Depends

Among older adults with mild-to-moderate depressive disorder diagnosed during a primary care visit, antidepressant medication or supervised group exercise sessions may decrease symptoms to a...

Low-Dose Nitrous Oxide Shows Benefit for Resistant Depression

A 1-hour treatment with a low concentration of nitrous oxide, commonly known as “laughing gas,” appears to relieve symptoms of treatment-resistant major depression (TRMD), with...

Anticholinergics a Key Contributor to Cognitive Impairment

Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. “The...

Hypertension Worsened by Commonly Used Prescription Meds

Nearly one out of five American adults with hypertension is on a prescription drug known to raise blood pressure, based on analysis of more than...

Novel Therapeutic Target for Depression Identified

An anti-seizure medication appears to reduce anhedonia in patients with depression via a novel mechanism that may offer a new therapeutic target for the disorder,...

Do Antidepressants Increase Risk of Brain Bleeds?

Contrary to previous findings, selective serotonin reuptake inhibitors (SSRI) are not associated with an increased risk of intracerebral hemorrhage (ICH), results of a large observational...

Depression, Chronic Comorbidities ‘Inextricably Linked’

For many adults, depression and chronic medical conditions are inextricably linked. In fact, the prevalence of depression is 2-10 times higher among people with chronic...

Antidepressant May Help COVID Patients Avoid Serious Illness

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The antidepressant fluvoxamine shows promise in preventing people infected with coronavirus...

Little Help, Possible Harm of Antidepressants for Pain

Antidepressants are of little help and may possibly be harmful in the treatment of musculoskeletal pain, new research suggests. Results of a systematic review and...

No Evidence That SNRIs Relieve Back Pain

While some guidelines support serotonin norepinephrine reuptake inhibitors (SNRIs) as treatments for back pain, a new systematic review and meta-analysis of existing research found no...

Late-Stage Lyme Disease and Psychiatric Illness: Final Verdict?

Lyme neuroborreliosis (LN), a late-stage manifestation of Lyme disease, is not associated with an increased risk of developing serious psychiatric illness, results of a large,...

ECG Promising for Predicting Major Depression, Treatment Response

Individuals with major depressive disorder (MDD) have an increased heart rate — a finding that may have the potential to identify individuals at risk for...

New Data on Birth Defects With Antidepressant Use in Pregnancy

Use of venlafaxine (Effexor), a serotonin-norepinephrine reuptake inhibitor (SNRI), is associated with more birth defects than any other antidepressant taken in the first months of...

Caution Urged for Antidepressant Use in Bipolar Depression

Although patients with bipolar disorder commonly experience depressive symptoms, clinicians should be very cautious about treating them with antidepressants, especially as monotherapy, experts asserted in...

Drug-Drug Interactions Could Imperil COVID-19 Treatment

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. As Covid-19 has spread across the United States and the world,...

IV Esketamine, Ketamine Equally Effective for Resistant Depression

Intravenous (IV) esketamine is as safe and effective as IV ketamine for patients with treatment-resistant depression, new research suggests. “Our study was the first randomized...